Jia Xue, Wubin Qian, Sheng Guo, Jie Cai, Davy Ouyang, and Henry Q. Li
It is being increasingly recognized that cancers are collections of diverse immune, as well as genetic, diseases. Aspects such as the tumor microenvironment, and its immune components, play a critical role on tumor progression and response, and need to be fully investigated.
Studying stroma-specific components has been historically challenging; however, newer experimental animal models can provide excellent systems for investigating the TME. For example patient-derived xenograft (PDX) models allow for straightforward in silico separation of human and mouse content, providing a surrogate model for TME and tumor-stroma interaction studies.
CrownBio provides the world’s largest commercial collection of PDX models, and is completing whole transcriptome sequencing of this model panel. Downstream analyses are allowing investigation of human and mouse stroma and immune compartments, which are reviewed in this poster.
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2023-04-24
2021-10-29
landing_page
PDX/Databases